哈药股份：关于2025年向金融机构申请增加综合授信额度的公告

Group 1 - The core point of the article is that Harbin Pharmaceutical Group Co., Ltd. plans to apply for an increase in credit limit of 1.55 billion yuan from financial institutions for the year 2025 [1] - The funds will be used for various financial services including but not limited to bank working capital loans, bank acceptance bills, domestic and foreign letters of credit, and guarantees [1]